Hepcitaj-SV 400mg/100mg Tablet
Marketer
Taj Pharma India Ltd
Salt Composition
Sofosbuvir (400mg) + Velpatasvir (100mg)
Overview Hepcitaj-SV 400mg/100mg Tablet
Combivir-HC 400mg/100mg tablets contain a dual antiviral formulation indicated for chronic hepatitis C (HCV) treatment. This prescription medication combats the HCV virus to achieve infection resolution. Adhere strictly to the prescribed dosage and regimen; it may be taken with or without food, but consistently at the same time each day. Exceeding the recommended dose is unsafe. Pre-existing liver or kidney conditions must be disclosed to your physician. Concurrent alcohol consumption is detrimental and should be minimized or avoided entirely. Complete the full course for optimal therapeutic outcomes. Fatigue and cephalalgia are common adverse effects; adequate hydration and a nutritious diet can mitigate these. Always inform your doctor about all other medications or supplements before commencing treatment.
Uses of Hepcitaj-SV 400mg/100mg Tablet
Managing persistent Hepatitis C virus (HCV) infection
Major Benefits of Hepcitaj-SV 400mg/100mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Hepcitaj-SV 400mg/100mg tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
Common Side effects of Hepcitaj-SV 400mg/100mg Tablet:
- Headache
- Tiredness
How to use Hepcitaj-SV 400mg/100mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Hepcitaj-SV 400mg/100mg tablet whole; avoid chewing, crushing, or breaking it. It can be administered with or without food, although consistent timing is recommended.
How Hepcitaj-SV 400mg/100mg Tablet works:
Hepcitaj-SV 400mg/100mg tablets contain Sofosbuvir and Velpatasvir, a dual antiviral therapy. This treatment reduces the hepatitis C viral load, ultimately eliminating the virus from the bloodstream over time.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Hepcitaj-SV 400mg/100mg tablets lacks established safety data. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The medication Hepcitaj-SV 400mg/100mg Tablet is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Hepcitaj-SV 400mg/100mg tablets appear compatible. Available human data indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Driving ability may be impaired by Hepcitaj-SV 400mg/100mg Tablets, which can induce side effects. Concurrent use of Hepcitaj-SV 400mg/100mg Tablets and other hepatitis C medications might cause dizziness and blurred vision, potentially impacting driving safety.
KidneyCAUTION
The 400mg/100mg Hepcitaj-SV tablet requires careful administration in individuals with advanced kidney impairment. Dosage modification for Hepcitaj-SV 400mg/100mg tablets may be necessary; physician consultation is advised. Data on Hepcitaj-SV 400mg/100mg tablet use in such patients is limited. Dosage changes aren't suggested for those with mild to moderate kidney disease.
LiverSAFE IF PRESCRIBED
Patients with liver impairment can safely use Hepcitaj-SV 400mg/100mg tablets without dosage modification. Kidney disease, however, should be reported to your physician, as certain individuals may require routine liver function tests during treatment.
What if you forget to take Hepcitaj-SV 400mg/100mg Tablet :
Should you forget a Hepcitaj-SV 400mg/100mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Hepcitaj-SV 400mg/100mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Infectious Disease Treatments |
3,018 People bought this recently